Title

OncoLog, Volume 28, Number 03, July-September 1983

Authors

The University of Texas MD Anderson Cancer Center
Hwee-Yong Yap MD, The University of Texas MD Anderson Cancer Center
George R. Blumenschein MD, The University of Texas MD Anderson Cancer Center
Brian C. Barnes MD, The University of Texas MD Anderson Cancer Center
Frank C. Schell MD, The University of Texas MD Anderson Cancer Center
Gerald P. Bodey MD, The University of Texas MD Anderson Cancer Center
Herbert A. Fritsche Jr., PhD, The University of Texas MD Anderson Cancer Center

Files

Contents

• Cellular Studies Guide Scheduling of Ara-C Treatment for Patients with Acute Leukemia
• Potent Noncardiotoxic Drug Proves Effective for Metastatic Breast Cancer
• Factors Affecting Accurate Reading Of CEA Tumor Marker Levels Detailed

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date

1983

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Leukemia; Cytarabine; ARA-C; Breast Neoplasms; Neoplasm Metastasis; Biomarkers; Tumor; Tumor Biomarkers; Tumor Marker

Disciplines

History of Science, Technology, and Medicine | Oncology

Recommended Citation

The University of Texas MD Anderson Cancer Center; Yap, Hwee-Yong MD; Blumenschein, George R. MD; Barnes, Brian C. MD; Schell, Frank C. MD; Bodey, Gerald P. MD; and Fritsche, Herbert A. Jr., PhD, "OncoLog, Volume 28, Number 03, July-September 1983" (1983). OncoLog MD Anderson's Report to Physicians (All issues). 3.
https://openworks.mdanderson.org/oncolog/3